Celltrion Pharm Reports Individual Operating Profit of 47.7 Billion KRW Last Year, Up 102%
[Asia Economy Reporter Ji Yeon-jin] Celltrion Pharm announced on the 23rd that its individual sales last year reached 397.3 billion KRW, an increase of 70.72% compared to the previous year.
During this period, operating profit increased by 102.28% to 47.7 billion KRW, and net profit for the period rose by 65.13% to 34.5 billion KRW.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- The Second Donghak Ant Movement? ... Individual Investors Keep Buying Despite Foreign Sell-Offs [1-Minute Brief]
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The company stated, "Global product manufacturing expansion and growth in biosimilar sales, along with an expanded chemical pharmaceutical portfolio," adding, "Operating profit increased due to profit growth from sales increase and cost reduction."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
